Voglibose Glimepiride Tablet

Key Features :-
1. Triple action combination targeting multiple diabetes pathways.
2. Glimepiride stimulates insulin secretion from pancreatic beta cells.
3. Metformin reduces liver glucose production and improves insulin sensitivity.
4. Voglibose delays carbohydrate absorption, reducing post-meal glucose spikes.
5. Sustained release metformin for prolonged blood sugar control.
6. Lowers fasting and postprandial blood glucose effectively.
7. Helps prevent diabetic complications like neuropathy and retinopathy.
8. Weight neutral or may aid in weight loss.
9. Reduced risk of hypoglycemia compared to older drugs.
10. Convenient single tablet combining three antidiabetic agents for better compliance.